OPN is involved in a number of diseases, including MI, atherosclerosis, kidney injury, diabetes, and other chronic inflammatory diseases in experimental animal models [15,19,24,25,27,28,29] and is also a strong predictor of adverse outcomes in patients with CVDs [30,31,32]. This evidence concerns the gene SPP1 and atherosclerosis.